BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 1, 2010
View Archived Issues
Flibanserin improves HSDD symptoms in premenopausal women
Read More
Schering-Plough discloses new TNF-alpha production inhibitors
Read More
Biotie Therapies and Wyeth identify novel PDE inhibitors
Read More
Gruenenthal presents new bradykinin B1 receptor antagonists
Read More
UCB claims novel PI3K inhibitors
Read More
Diagnostic/prognostic gene expression signature identified for UCC
Read More
Regulus obtains license to microRNA-21 intellectual property
Read More
KB-001 shows clinical promise in P. aeruginosa infection
Read More
HRH1 gene SNP may predict response to OFC in depressed individuals
Read More
Gilead Sciences updates pipeline progress
Read More
Celgene discovers new TNF-alpha production inhibitors for cancer therapy
Read More
Aragen and Amorfix agree to co-develop cancer-targeting mAbs
Read More
FDA approves Photocure's Cysview for bladder cancer detection
Read More
German Health Agency sends official calendar for bilastine registration procedure
Read More
Cyberonics reports on postmarket VNS Therapy trial in depression
Read More
Synergy of ipilimumab and androgen ablation reported in prostate cancer
Read More
YM opens phase II nimotuzumab trial in patients with brain metastases from NSCLC
Read More
AstraZeneca and NIH's NIDDK collaborate to support DILIN
Read More
VaxGen to acquire diaDexus under revised merger agreement
Read More
Tesaro secures funds to acquire and develop cancer therapeutics
Read More
Noxxon Pharma raises funds for lead product development
Read More
ARCA launches phase I trial of GeoVax Labs' HIV vaccine
Read More
CytRx begins phase II bafetinib trial in B-cell chronic lymphocytic leukemia
Read More
Wyeth Europa notifies EMA of withdrawal of MAA for Brilence
Read More
Preclinical data demonstrate antileukemic effects of OXiGENE's OXi-4503
Read More